Characterizing the epidemiological transition in Mexico: national and subnational burden of diseases, injuries, and risk factors

Gretchen Stevens, Rodrigo H Dias, Kevin J A Thomas, Juan A Rivera, Natalie Carvalho, Simón Barquera, Kenneth Hill, Majid Ezzati, Gretchen Stevens, Rodrigo H Dias, Kevin J A Thomas, Juan A Rivera, Natalie Carvalho, Simón Barquera, Kenneth Hill, Majid Ezzati

Abstract

Background: Rates of diseases and injuries and the effects of their risk factors can have substantial subnational heterogeneity, especially in middle-income countries like Mexico. Subnational analysis of the burden of diseases, injuries, and risk factors can improve characterization of the epidemiological transition and identify policy priorities.

Methods and findings: We estimated deaths and loss of healthy life years (measured in disability-adjusted life years [DALYs]) in 2004 from a comprehensive list of diseases and injuries, and 16 major risk factors, by sex and age for Mexico and its states. Data sources included the vital statistics, national censuses, health examination surveys, and published epidemiological studies. Mortality statistics were adjusted for underreporting, misreporting of age at death, and for misclassification and incomparability of cause-of-death assignment. Nationally, noncommunicable diseases caused 75% of total deaths and 68% of total DALYs, with another 14% of deaths and 18% of DALYs caused by undernutrition and communicable, maternal, and perinatal diseases. The leading causes of death were ischemic heart disease, diabetes mellitus, cerebrovascular disease, liver cirrhosis, and road traffic injuries. High body mass index, high blood glucose, and alcohol use were the leading risk factors for disease burden, causing 5.1%, 5.0%, and 7.3% of total burden of disease, respectively. Mexico City had the lowest mortality rates (4.2 per 1,000) and the Southern region the highest (5.0 per 1,000); under-five mortality in the Southern region was nearly twice that of Mexico City. In the Southern region undernutrition and communicable, maternal, and perinatal diseases caused 23% of DALYs; in Chiapas, they caused 29% of DALYs. At the same time, the absolute rates of noncommunicable disease and injury burdens were highest in the Southern region (105 DALYs per 1,000 population versus 97 nationally for noncommunicable diseases; 22 versus 19 for injuries).

Conclusions: Mexico is at an advanced stage in the epidemiologic transition, with the majority of the disease and injury burden from noncommunicable diseases. A unique characteristic of the epidemiological transition in Mexico is that overweight and obesity, high blood glucose, and alcohol use are responsible for larger burden of disease than other noncommunicable disease risks such as tobacco smoking. The Southern region is least advanced in the epidemiological transition and suffers from the largest burden of ill health in all disease and injury groups.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1. Steps of the Analysis
Figure 1. Steps of the Analysis
All calculations were carried out by age group, sex, and state. National and regional estimates of deaths, DALYs, and attributable disease burden were calculated as the sum of state estimates.
Figure 2. Age-Standardized Mortality Rates (A) and…
Figure 2. Age-Standardized Mortality Rates (A) and Burden of Disease Rates (B) for Mexico and Its Regions, Divided by Disease Category
For comparison, the figure also shows mortality rates for all high-income and low-and-middle-income countries [52]. All rates are standardized to the 2000 national population of Mexico. Regions used to present results are: Northern: Baja California, Baja California Sur, Coahuila, Chihuahua, Nuevo León, Sonora, Tamaulipas; Pacific Central: Aguascalientes, Colima, Jalisco; Central: Durango, Guanajuato, Michoacán, Morelos, Nayarit, Querétaro, San Luis Potosí, Sinaloa, Tlaxcala, Zacatecas, and parts of Mexico State not in the Mexico City region; Mexico City: Distrito Federal and parts of Mexico State in the contiguous urban area; Gulf: Campeche, Quintana Roo, Tabasco, Veracruz, Yucatán; Southern: Chiapas, Guerrero, Hidalgo, Oaxaca, and Puebla (Table S1). Key: Ca, cancers; Cir, liver cirrhosis; Com, communicable; CVD, cardiovascular; DM, diabetes; Inj, injuries; Mat, maternal, perinatal, and nutritional; NCom, other noncommunicable; NP, neuropsychiatric.
Figure 3. National and Regional Under-Five Mortality…
Figure 3. National and Regional Under-Five Mortality Rates, Divided by Disease Category
For comparison, the figure also shows the rates for all high-income, upper- and lower-middle-income, and low-income countries [52]. Key: Com, other communicable; Diar, diarrhea; Inj, injuries; NCom, other noncommunicable; Perinatal, perinatal; Resp, respiratory infections.
Figure 4. Mortality (A) and Burden of…
Figure 4. Mortality (A) and Burden of Disease (B) Attributable to Leading Risk Factors in Four Mexican Regions, Divided by Disease Category
The rates in this figure were not age-standardized. Therefore, the observed regional variation in attributable mortality and burden of disease is partly due to regional variation in age structure. Key: Ca, cancers; Cir, liver cirrhosis; Com, communicable; CVD, cardiovascular; DM, diabetes; Inj, injuries; Mat, maternal, perinatal, and nutritional; NCom, other noncommunicable.
Figure 5. Under-Five Mortality Attributable to Leading…
Figure 5. Under-Five Mortality Attributable to Leading Risk Factors in Four Mexican Regions, Divided by Disease Category
Key: Comm, other communicable; Diar, diarrhea; Inj, injuries; NCom, other noncommunicable; Perinatal, perinatal; Resp, respiratory infections.

References

    1. Lozano R, Murray CJL, Frenk J, Bobadilla JL. Burden of disease assessment and health system reform: results of a study in Mexico. J Int Dev. 1995;7:555–563.
    1. Murray CJL, Lopez AD. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Boston: Harvard School of Public Health; 1996. 990 p.
    1. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJL, et al. Selected major risk factors and global and regional burden of disease. Lancet. 2002;360:1347–1360.
    1. Michaud CM, McKenna MT, Begg S, Tomijima N, Majmudar M, et al. The burden of disease and injury in the United States 1996. Popul Health Metr. 2006;4:11.
    1. Mahapatra P. Estimating national burden of disease: the burden of disease in Andhra Pradesh, 1990′s. Hyderabad: Institute of Health Systems; 2002.
    1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367:1747–1757.
    1. Begg S, Vos T, Barker B, Stevenson C, Stanley L, et al. The burden of disease and injury Australia 2003. Canberra: Australian Institute of Health and Welfare; 2007. 337 p.
    1. Bradshaw D, Nannan N, Groenewald P, Joubert J, Laubscher R, et al. Provincial mortality in South Africa, 2000–priority-setting for now and a benchmark for the future. S Afr Med J. 2005;95:496–503.
    1. Murray CJL, Kulkarni SC, Michaud C, Tomijima N, Bulzacchelli MT, et al. Eight Americas: investigating mortality disparities across races, counties, and race-counties in the United States. PLoS Medicine. 2006. e260. doi: .
    1. Preston SH. Mortality patterns in national populations, with special reference to recorded causes of death. New York: Academic Press; 1976. 212 p.
    1. Omran AR. The epidemiologic transition: a theory of the epidemiology of population change. Milbank Mem Fund Q. 1971;49:509–538.
    1. Salomon J, Murray CJL. The epidemiologic transition revisited: compositional models for causes of death by age and sex. Popul Dev Rev. 2002;28:205–228.
    1. Frenk J, Bobadilla JL, Sepúlveda Amor JA, López Cervantes M. Health transition in middle-income countries: new challenges for health care. Health Policy Plan. 1989;41:29–39.
    1. Frenk J, Bobadilla JL, Stern MP. Elements for a theory of the health transition. Health Transit Rev 1. 1991. pp. 21–38.
    1. González Pier E, Gutiérrez Delgado C, Stevens G, Barranza Lloréns M, Porras Condey R, et al. Priority-setting for health interventions in Mexico's system of social protection in health. Lancet. 2006;368:1608–1618.
    1. Brass W. Methods for estimating fertility and mortality from limited and defective data. Chapel Hill (North Carolina): University of North Carolina, Chapel Hill; 1975.
    1. Hill K. Estimating census and death registration completeness. Asian Pac Popul Forum. 1987;1:8–13. 23–24.
    1. United Nations. Manual X: indirect techniques for demographic estimation. New York: United Nations; 1983.
    1. Coale AJ, Demeny P. In: Regional model life tables and stable populations. Vaughn B, editor. Princeton (New Jersey): Princeton University Press; 1983.
    1. Mathers CD, Lopez AD, Murray CJL. The burden of disease and mortality by condition: data, methods, and results for 2001. In: Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL, editors. Global burden of disease and risk factors. Washington (D.C.): Oxford University Press and The World Bank; 2006. pp. 45–240.
    1. Murray CJ, Kulkarni SC, Ezzati M. Understanding the coronary heart disease versus total cardiovascular mortality paradox: a method to enhance the comparability of cardiovascular death statistics in the United States. Circulation. 2006;113:2071–2081.
    1. Murray C, Dias RH, Kulkarni SC, Lozano R, Stevens GA, et al. Improving the comparability of diabetes mortality statistics in the United States and Mexico. Diabetes Care. 2007;31:451–458.
    1. Mathers CD, Salomon JA, Ezzati M, Begg S, Vander Hoorn S, et al. Sensitivity and uncertainty analysis for burden of disease and risk factor estimates. In: Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ, editors. Global burden of disease and risk factors. Washington (D.C.): The World Bank; 2006. pp. 399–426.
    1. Ezzati M, Lopez AD, Rodgers A, Murray CJL. Comparative quantification of health risks: global and regional burden of disease attributable to selected major risk factors. Geneva: World Health Organization; 2004. 2248 p.
    1. Ezzati M, Hoorn SV, Rodgers A, Lopez AD, Mathers CD, et al. Estimates of global and regional potential health gains from reducing multiple major risk factors. Lancet. 2003;362:271–280.
    1. Olaiz Fernández G, Rivera Dommarco JA, Shamah Levy T, Rojas R, Villalpando Hernández S, et al. Encuesta nacional de salud y nutrición 2006. Cuernavaca, Mexico: Instituto Nacional de Salud Pública; 2006.
    1. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937–952.
    1. Oficina de la Presidencia. Quinto informe de gobierno del c. presidente constitucional de los Estados Unidos Mexicanos. México, D.F.: Presidencia de la República; 2005. 420 p.
    1. Ndong I, Gloyd S, Gale J. An evaluation of vital registers as sources of data for infant mortality rates in Cameroon. Int J Epidemiol. 1994;23:536–539.
    1. Al-Rabee K, Alkafajei A. Evaluation of child deaths registration in a Jordanian community. East Mediterr Health J. 2006;12:23–34.
    1. Tome P, Reyes H, Pina C, Rodriguez L, Gutierrez G. [Characteristics associated with under-registration of children's deaths in the state of Guerrero, Mexico] Salud Publica de Mexico. 1997;39:523–529.
    1. Peden M, Scurfield R, Sleet D, Mohan D, Hyder AA, et al., editors. World report on road traffic injury prevention. Geneva: World Health Organization; 2004. 203 p.
    1. Danaei G, Lawes CMM, vander Hoorn S, Murray CJL, Ezzati M. Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment. Lancet. 2006;368:1651–1659.
    1. Ezzati M, Vander Hoorn S, Lawes CM, Leach R, James WP, et al. Rethinking the “diseases of affluence” paradigm: global patterns of nutritional risks in relation to economic development. PLoS Medicine. 2005. e133. doi: .
    1. Posadas-Romero C, Tapia-Conyer R, Lerman-Garber I, Zamora-Gonzalez J, Cardoso-Saldana G, et al. Cholesterol levels and prevalence of hypercholesterolemia in a Mexican adult population. Atherosclerosis. 1995;118:275–284.
    1. Barquera S, Flores M, Olaiz-Fernández G, Monterrubio E, Villalpando S, et al. Dyslipidemias and obesity in Mexico. Salúd Publica de México. 2007;49:S338–S347.
    1. Instituto Nacional de Estadística Geografía e Informática. Encuesta nacional de adicciones 2002. Aguascalientes (México): Instituto Nacional de Estadística Geografía e Informática; 2004. 149 p.
    1. Shafey O, Dolwick S, Guindon G, editors. American Cancer Society. Tobacco control country profiles. Atlanta (Georgia): American Cancer Society; 2003.
    1. Rivera JA, Barquera S, Campirano F, Campos I, Safdie M, et al. Epidemiological and nutritional transition in Mexico: rapid increase of non-communicable chronic diseases and obesity. Public Health Nutr. 2002;5:113–122.
    1. Ezzati M, Martin H, Skjold S, Vander Hoorn S, Murray CJ. Trends in national and state-level obesity in the USA after correction for self-report bias: analysis of health surveys. J R Soc Med. 2006;99:250–257.
    1. Ezzati M, Oza S, Danaei G, Murray CJ. Trends and cardiovascular mortality effects of state-level blood pressure and uncontrolled hypertension in the United States. Circulation. 2008;117:905–914.
    1. Willett W, Stampfer MJ. Total energy intake: implications for epidemiologic analysis. Am J Epidemiol. 1986;124:17–27.
    1. Harvard University, Secretaría de Salud, Instituto Nacional de Salud Pública. Evaluation of the system for social protection in health. Cambridge (Massachusetts): Harvard University; 2006.
    1. Rehm J, Room R, Monteiro M, Gmel G, Graham K, et al. In: Alcohol use. Comparative quantification of health risks. Ezzati M, Lopez AD, Rodgers A, Murray CJL, editors. Geneva: World Health Organization; 2004. pp. 959–1108.
    1. Szucs S, Sarvary A, McKee M, Adany R. Could the high level of cirrhosis in central and eastern Europe be due partly to the quality of alcohol consumed? An exploratory investigation. Addiction. 2005;100:536–542.
    1. Kerr WC, Fillmore KM, Marvy P. Beverage-specific alcohol consumption and cirrhosis mortality in a group of English-speaking beer-drinking countries. Addiction. 2000;95:339–346.
    1. Narro-Robles J, Gutierrez-Avila JH, Lopez-Cervantes M, Borges G, Rosovsky H. [Liver cirrhosis mortality in Mexico. II. Excess mortality and pulque consumption] Salud Publica de Mexico. 1992;34:388–405.
    1. Narro-Robles J, Gutierrez-Avila JH. [Ecological correlation between consumption of alcoholic beverages and liver cirrhosis mortality in Mexico] Salud Publica de Mexico. 1997;39:217–220.
    1. Silveira TR, da Fonseca JC, Rivera L, Fay OH, Tapia R, et al. Hepatitis B seroprevalence in Latin America. Rev Panam Salud Publica. 1999;6:378–383.
    1. Valdespino J, Conde-Gonzalez C, Olaiz-Fernandez G, Palma O, Kershenobich D, et al. [Seroprevalence of hepatitis C among Mexican adults: an emerging public health problem?] Salud Publica de Mexico. 2007;49:S395–S403.
    1. James O. Non-alcoholic steatohepatitis. Medicine. 2002;30:62.
    1. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Medicine. 2006. e442. doi: .

Source: PubMed

3
Prenumerera